Cours suspendu

Communiqués Hologic, Inc.

Actions

HOLX

US4364401012

Equipement et technologie médicale avancés

Temps Différé Nasdaq Autres places de cotation 22:00:00 06/04/2026			Varia. 5j.	Varia. 1 janv.
76,01 ^USD	+0,48%		-.--%	+2,04%

30/06	Hologic rappelle ses marqueurs implantables BioZorb, selon la FDA	MT
26/05	Hologic et Biotheranostics présentent de nouvelles données sur le test Breast Cancer Index lors de l'ASCO 2026	CI

Communiqués

07/04	Blackstone and TPG Complete Acquisition of Hologic	BU
06/04	Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction	BU
17/03	1,5 milliard de femmes privées d’examens préventifs essentiels malgré une légère hausse des taux de dépistage à l’échelle mondiale	BU
17/03	1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates	BU
05/02	Hologic Receives FDA Approval for Aptima HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio	AQ
04/02	Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio	BU
29/01	Hologic: Fiscal Q1 Earnings Snapshot	AQ
16/01	Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic	AQ
16/01	Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026	BU
13/01	Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening	BU
16/12	Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams	BU
02/12	New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration	BU
26/11	New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNA	AQ
25/11	New Clinical Evidence on Hologic’s AI-Powered Mammography Solutions Will Be Unveiled at RSNA	BU
18/11	Hologic : Annual Report for Fiscal Year Ending September 27, 2025 (Form 10-K)	PU
12/11	Hologic Introduces Digital Pathology Capabilities With Expanded CE Marking	BU
03/11	Hologic: Fiscal Q4 Earnings Snapshot	AQ
29/10/25	HOLX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Hologic to Blackstone and TPG	AQ
22/10/25	Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX	BU
21/10/25	Blackstone, TPG plan to take Hologic private in a deal worth more than $13 billion	AQ
02/10/25	Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025	BU
02/10/25	Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis	BU
30/09/25	New Survey Results Underscore the Need to #BustTheMyth About Mammograms	BU
29/09/25	Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm	PR
26/09/25	New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at EUSOBI	BU